Prenetics Global Limited (PRE)
NASDAQ: PRE · Real-Time Price · USD
3.920
+0.070 (1.82%)
At close: Mar 31, 2025, 4:00 PM
4.130
+0.210 (5.36%)
After-hours: Mar 31, 2025, 5:25 PM EDT
Prenetics Global Revenue
Prenetics Global had revenue of $7.78M in the quarter ending September 30, 2024, with 59.86% growth. This brings the company's revenue in the last twelve months to $25.56M, down -90.86% year-over-year. In the year 2023, Prenetics Global had annual revenue of $21.74M with 65.17% growth.
Revenue (ttm)
$25.56M
Revenue Growth
-90.86%
P/S Ratio
1.89
Revenue / Employee
$78,893
Employees
324
Market Cap
47.89M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 21.74M | 8.58M | 65.17% |
Dec 31, 2022 | 13.16M | 631.10K | 5.04% |
Dec 31, 2021 | 12.53M | -52.65M | -80.77% |
Dec 31, 2020 | 65.18M | 55.95M | 605.93% |
Dec 31, 2019 | 9.23M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
PRE News
- 13 days ago - Prenetics' IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market - GlobeNewsWire
- 26 days ago - Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance - GlobeNewsWire
- 6 weeks ago - Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic Reserve - GlobeNewsWire
- 2 months ago - Prenetics' IM8 Achieves Prestigious NSF Certified for Sport® for Daily Ultimate Essentials - GlobeNewsWire
- 4 months ago - Prenetics' IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services - GlobeNewsWire
- 4 months ago - Prenetics Announces Participation in December Investor Conferences - GlobeNewsWire
- 4 months ago - Prenetics Announces Third Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - MULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health - GlobeNewsWire